Literature DB >> 34605048

Labor market participation and productivity costs for female caregivers of minor male children with Duchenne and Becker muscular dystrophies.

Rieza H Soelaeman1, Michael G Smith2, Kashika Sahay3, J Mick Tilford4, Dana Goodenough5, Pangaja Paramsothy1, Lijing Ouyang1, Joyce Oleszek6,7, Scott D Grosse1.   

Abstract

INTRODUCTION/AIMS: Duchenne and Becker muscular dystrophies (DBMD) are X-linked neuromuscular disorders characterized by progressive muscle weakness, leading to decreased mobility and multisystem complications. We estimate productivity costs attributable to time spent by a parent caring for a male child under the age of 18 y with DBMD, with particular focus on female caregivers of boys with Duchenne muscular dystrophy (DMD) who have already lost ambulation.
METHODS: Primary caregivers of males with DBMD in the Muscular Dystrophy Surveillance and Research Tracking Network (MD STARnet) were surveyed during 2011-2012 on family quality of life measures, including labor market outcomes. Of 211 respondents, 96 female caregivers of boys with DBMD were matched on state, year of survey, respondent's age, child's age, and number of minor children with controls constructed from Current Population Survey extracts. Regression analysis was used to estimate labor market outcomes and productivity costs.
RESULTS: Caregivers of boys with DBMD worked 296 h less per year on average than caregivers of unaffected children, translating to a $8816 earnings loss in 2020 U.S. dollars. Caregivers of boys with DMD with ≥4 y of ambulation loss had a predicted loss in annualized earnings of $23,995, whereas caregivers of boys with DBMD of the same ages who remained ambulatory had no loss of earnings. DISCUSSION: Female caregivers of non-ambulatory boys with DMD face additional household budget constraints through income loss. Failure to include informal care costs in economic studies could understate the societal cost-effectiveness of strategies for managing DMD that might prolong ambulation.
© 2021 Wiley Periodicals LLC. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  Becker muscular dystrophy; Duchenne muscular dystrophy; disability; informal care; productivity costs

Mesh:

Year:  2021        PMID: 34605048      PMCID: PMC8595851          DOI: 10.1002/mus.27429

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.852


  32 in total

1.  A national profile of health care and family impacts of children with muscular dystrophy and special health care needs in the United States.

Authors:  Lijing Ouyang; Scott D Grosse; Michael H Fox; Julie Bolen
Journal:  J Child Neurol       Date:  2011-09-27       Impact factor: 1.987

2.  Correlates of care for young men with Duchenne and Becker muscular dystrophy.

Authors:  Jennifer G Andrews; Melinda F Davis; F John Meaney
Journal:  Muscle Nerve       Date:  2013-09-11       Impact factor: 3.217

3.  Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia.

Authors:  Sara C Atehortúa; Luz H Lugo; Mateo Ceballos; Esteban Orozco; Paula A Castro; Juan C Arango; Heidi E Mateus
Journal:  Value Health Reg Issues       Date:  2018-03-10

4.  Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.

Authors:  Rebecca Latimer; Natalie Street; Kristin Caspers Conway; Kathy James; Christopher Cunniff; Joyce Oleszek; Deborah Fox; Emma Ciafaloni; Christina Westfield; Pangaja Paramsothy
Journal:  J Child Neurol       Date:  2017-04-09       Impact factor: 1.987

5.  Economic productivity by age and sex: 2007 estimates for the United States.

Authors:  Scott D Grosse; Kurt V Krueger; Mercy Mvundura
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

6.  Parental stress in mothers of boys with duchenne muscular dystrophy.

Authors:  Nancy E Nereo; Robert J Fee; Veronica J Hinton
Journal:  J Pediatr Psychol       Date:  2003 Oct-Nov

7.  Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.

Authors:  Marianna Cavazza; Yllka Kodra; Patrizio Armeni; Marta De Santis; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-02

8.  Parental perspectives on the financial impact of caring for a child with CKD.

Authors:  Meredith Medway; Allison Tong; Jonathan C Craig; Siah Kim; Fiona Mackie; Steven McTaggart; Amanda Walker; Germaine Wong
Journal:  Am J Kidney Dis       Date:  2014-09-20       Impact factor: 8.860

Review 9.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.

Authors:  S Ryder; R M Leadley; N Armstrong; M Westwood; S de Kock; T Butt; M Jain; J Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

10.  Perceived quality of life among caregivers of children with a childhood-onset dystrophinopathy: a double ABCX model of caregiver stressors and perceived resources.

Authors:  Natalia Frishman; Kristin Caspers Conway; Jennifer Andrews; Jacob Oleson; Katherine Mathews; Emma Ciafaloni; Joyce Oleszek; Molly Lamb; Dennis Matthews; Pangaja Paramsothy; Lowell McKirgan; Paul Romitti
Journal:  Health Qual Life Outcomes       Date:  2017-02-10       Impact factor: 3.186

View more
  1 in total

1.  The Role of Associations in Reducing the Emotional and Financial Impact on Parents Caring for Children with Duchenne Muscular Dystrophy: A Cross-Cultural Study.

Authors:  Alicia Aurora Rodríguez; Imanol Amayra; Juan Francisco López-Paz; Oscar Martínez; Maitane García; Mónika Salgueiro; Mohammad Al-Rashaida; Paula María Luna; Paula Pérez-Nuñez; Nicole Passi; Irune García; Javiera Ortega
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.